Varenicline as a Quit Smoking Aid
Varenicline tartrate is a smoking cessation drug that was discovered and developed by Pfizer, Inc. Marketed as Chantix™, it has the unique ability to partially activate nicotinic receptors in the brain, reducing a person's craving for nicotine when they quit smoking.
Chantix Side Effects - Is Chantix Safe to Use?
A reader asks: "I'm afraid to use Chantix because of all of the negative news I've been reading about Chantix side effects. Can you tell me what the side effects of Chantix are and whether Chantix is dangerous for me to use to quit smoking?"
A reader asks: "I'm afraid to use Chantix because of all of the negative news I've been reading about Chantix side effects. Can you tell me what the side effects of Chantix are and whether Chantix is dangerous for me to use to quit smoking?"
Chantix FAQs
Varenicline tartrate, brand name Chantix™ is a smoking cessation medication that was developed by Pfizer, Inc. In May of 2006, Chantix was approved for use by the Food and Drug Administration(FDA). In the years since however, a number of serious concerns involving changes in mood and behavior for people taking using Chantix have surfaced.
Varenicline tartrate, brand name Chantix™ is a smoking cessation medication that was developed by Pfizer, Inc. In May of 2006, Chantix was approved for use by the Food and Drug Administration(FDA). In the years since however, a number of serious concerns involving changes in mood and behavior for people taking using Chantix have surfaced.
Using Chantix to Help You Quit Smoking
Varenicline tartrate, marketed under the name of Chantix™, was discovered and developed by Pfizer, Inc. Chantix has the unique ability to partially activate sites in the brain that are affected by nicotine, as well as neutralizing the effects of nicotine should a person smoke while using this drug.
Varenicline tartrate, marketed under the name of Chantix™, was discovered and developed by Pfizer, Inc. Chantix has the unique ability to partially activate sites in the brain that are affected by nicotine, as well as neutralizing the effects of nicotine should a person smoke while using this drug.
Chantix Patient Information
Chantix has the unique ability to partially activate nicotinic receptors in the brain, reducing a person's craving for nicotine when they quit smoking.
Chantix has the unique ability to partially activate nicotinic receptors in the brain, reducing a person's craving for nicotine when they quit smoking.
Chantix Testimonials
When evaluating a particular quit smoking therapy, it's helpful to hear how other people have felt when using it. This list of pros and cons comes from those who have used varenicline tartrate (Chantix™) to help them quit smoking.
When evaluating a particular quit smoking therapy, it's helpful to hear how other people have felt when using it. This list of pros and cons comes from those who have used varenicline tartrate (Chantix™) to help them quit smoking.
Varenicline as a Quit Smoking Aid
Varenicline tartrate is a smoking cessation drug that was discovered and developed by Pfizer, Inc. Marketed as Chantix™.
Varenicline tartrate is a smoking cessation drug that was discovered and developed by Pfizer, Inc. Marketed as Chantix™.
Varenicline Information from About.com Drugs A-Z
Patient information for using varenicline tartrate tablets.
Patient information for using varenicline tartrate tablets.